[
  {
    "ts": null,
    "headline": "Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering",
    "summary": "New Spherix Global Insights data reveal growing physician demand for therapies that reduce treatment burden and elevate patient experience.EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch Dynamix™ trackers for Qfitlia (Sanofi), Hympavzi (Pfizer), and Alhemo (Novo Nordisk). The new research from",
    "url": "https://finnhub.io/api/news?id=d7bf95b7ba08ac3c5820b8bb877ca6123fad7e7bcce97a5bc77713118a0a4699",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761148620,
      "headline": "Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering",
      "id": 137188275,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "New Spherix Global Insights data reveal growing physician demand for therapies that reduce treatment burden and elevate patient experience.EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch Dynamix™ trackers for Qfitlia (Sanofi), Hympavzi (Pfizer), and Alhemo (Novo Nordisk). The new research from",
      "url": "https://finnhub.io/api/news?id=d7bf95b7ba08ac3c5820b8bb877ca6123fad7e7bcce97a5bc77713118a0a4699"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Up More Than 30% in 6 Months: How to Play the Stock",
    "summary": "AbbVie's 30% surge in six months is powered by booming sales of Skyrizi and Rinvoq and renewed strength across oncology and neuroscience.",
    "url": "https://finnhub.io/api/news?id=c5478020a0a180250eee2286239d697b9f2bfdb30270368d7c77ab439e109122",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761143340,
      "headline": "AbbVie Up More Than 30% in 6 Months: How to Play the Stock",
      "id": 137187813,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "AbbVie's 30% surge in six months is powered by booming sales of Skyrizi and Rinvoq and renewed strength across oncology and neuroscience.",
      "url": "https://finnhub.io/api/news?id=c5478020a0a180250eee2286239d697b9f2bfdb30270368d7c77ab439e109122"
    }
  },
  {
    "ts": null,
    "headline": "Flagship Pioneering Unveils Expedition Medicines to Expand the Boundaries of Small Molecule Medicines with Generative Design",
    "summary": "Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today unveiled Expedition Medicines™, a company pioneering generative covalent chemistry to expand the boundaries of medicine. Following three years of in-house development, Flagship has committed an initial $50 million to support scaling Expedition's platform for generating small molecule medicines to any target and to further develop its discovery programs in oncology, immunology, and other well-defi",
    "url": "https://finnhub.io/api/news?id=37e33f74cb4283458a13d6847a3bfe939ef4d51d472dbcbc7b61884da3e96548",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761129000,
      "headline": "Flagship Pioneering Unveils Expedition Medicines to Expand the Boundaries of Small Molecule Medicines with Generative Design",
      "id": 137188277,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today unveiled Expedition Medicines™, a company pioneering generative covalent chemistry to expand the boundaries of medicine. Following three years of in-house development, Flagship has committed an initial $50 million to support scaling Expedition's platform for generating small molecule medicines to any target and to further develop its discovery programs in oncology, immunology, and other well-defi",
      "url": "https://finnhub.io/api/news?id=37e33f74cb4283458a13d6847a3bfe939ef4d51d472dbcbc7b61884da3e96548"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Scientific Revenue Rises, Boosted by Life Sciences Business",
    "summary": "The scientific services company recorded third-quarter sales of $11.12 billion on the back of growth in its life sciences business.",
    "url": "https://finnhub.io/api/news?id=d4e8a74f141a8f3c8bacf9e960823708a90cae7cb6f71c92570b586c8da97ec2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761128820,
      "headline": "Thermo Scientific Revenue Rises, Boosted by Life Sciences Business",
      "id": 137188278,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The scientific services company recorded third-quarter sales of $11.12 billion on the back of growth in its life sciences business.",
      "url": "https://finnhub.io/api/news?id=d4e8a74f141a8f3c8bacf9e960823708a90cae7cb6f71c92570b586c8da97ec2"
    }
  }
]